Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

Killer immunoglobulin-like receptors (KIRs) are expressed on natural killer cells and some T-cell subsets and produce either activation or inhibitory signals upon binding with the appropriate human leucocyte antigen (HLA) ligand on target cells. Recent genetic association studies have implicated KIR...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Jones, D, Edgar, R, Ahmad, T, Cummings, JR, Jewell, D, Trowsdale, J, Young, N
Natura:	Journal article
Lingua:	English
Pubblicazione:	2006

Documenti analoghi

Association of Killer Cell Immunoglobulin-like Receptor (KIR) Genes and their HLA Ligands with Susceptibility to Takayasu Arteritis in the Iranian Population
di: Fereshteh Beigmohammadi, et al.
Pubblicazione: (2023-02-01)

Genotypic diversity of the Killer Cell Immunoglobulin-like Receptors (KIR) and their HLA class I Ligands in a Saudi population
di: Suliman Y. Al Omar, et al.
Pubblicazione: (2016-03-01)

Ulcerative colitis and HLA phenotype.
di: Cottone, M, et al.
Pubblicazione: (1985)

Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
di: Gibson, P, et al.
Pubblicazione: (1985)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population
di: Daniela Maira Cardozo, et al.
Pubblicazione: (2023-07-01)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
di: Antonino Tuttolomondo, et al.
Pubblicazione: (2019-04-01)

Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population.
di: Hiromi Saito, et al.
Pubblicazione: (2018-01-01)

The association of the killer cell immunoglobulin-like receptor (KIR) genotype distribution and HLA-C ligands in colorectal cancer in the eastern region of Saudi Arabia
di: Sarah Alqadheeb, et al.
Pubblicazione: (2024-07-01)

Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study
di: Viktoria Varbanova, et al.
Pubblicazione: (2019-11-01)

Relationship between KIR genotypes and HLA-ligands with SARS-CoV-2 infection in the Saudi population
di: Suliman Alomar, et al.
Pubblicazione: (2023-01-01)

Oral methotrexate in ulcerative colitis.
di: Cummings, JR, et al.
Pubblicazione: (2005)

Natural Killer Cells and Cancer--Regulation by the Killer Cell Ig-like Receptors (KIR)
di: Amanda K. PURDY, et al.
Pubblicazione: (2010-07-01)

Ulcerative colitis and Crohn's disease--susceptibility genes and clinical patterns.
di: Jewell, D
Pubblicazione: (1998)

KIR-HLA gene diversities and susceptibility to lung cancer
di: Marjan Hematian Larki, et al.
Pubblicazione: (2022-10-01)

Ulcerative colitis.
di: Jewell, D
Pubblicazione: (1975)

HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.
di: Aura Burian, et al.
Pubblicazione: (2016-01-01)

Colonic bacterial proteases to IgA1 and sIgA in patients with ulcerative colitis.
di: Barr, G, et al.
Pubblicazione: (1987)

Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation
di: Davood Jafari, et al.
Pubblicazione: (2017-06-01)

Killer Cell Ig-like Receptors (KIR)-Binding Assay for Tumor Cells
di: Loredana Cifaldi, et al.
Pubblicazione: (2016-09-01)

Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
di: Jing-Jie Guo, et al.
Pubblicazione: (2022-11-01)

Aetiopathogenesis of ulcerative colitis.
di: Jewell, D
Pubblicazione: (1987)

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
di: Chrissy H Roberts, et al.
Pubblicazione: (2014-03-01)

Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity
di: Stephen Tukwasibwe, et al.
Pubblicazione: (2021-02-01)

Association of genetic variants of KIR2DL4 and its ligand HLA-G gene with HCV susceptibility and chronicity
di: Ze-pei FENG, et al.
Pubblicazione: (2023-03-01)

HLA TYPING OF ULCERATIVE COLITIS IN IRAN
di: Froutan, et al.
Pubblicazione: (1996-06-01)

HLA TYPING OF ULCERATIVE COLITIS IN IRAN
di: Froutan, et al.
Pubblicazione: (1996-06-01)

Azathioprine in ulcerative colitis.
di: Jewell, D, et al.
Pubblicazione: (1972)

Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop
di: Misra, MK, et al.
Pubblicazione: (2018)

Infliximab for ulcerative colitis.
di: Simmons, J, et al.
Pubblicazione: (2002)

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.
di: Ying Qi, et al.
Pubblicazione: (2006-08-01)

Proceedings: Etiology of ulcerative colitis.
di: Jewell, D
Pubblicazione: (1973)

Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands
di: Hatano, H, et al.
Pubblicazione: (2013)

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
di: Rehan Mujeeb Faridi, et al.
Pubblicazione: (2016-01-01)

Ulcerative colitis and sarcoidosis.
di: Barr, G, et al.
Pubblicazione: (1986)

Reaginic hypersensitivity in ulcerative colitis.
di: Jewell, D, et al.
Pubblicazione: (1972)

Disodium azodisalicylate in ulcerative colitis.
di: Jewell, D, et al.
Pubblicazione: (1981)

Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response
di: Vlad Andrei Cianga, et al.
Pubblicazione: (2023-03-01)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
di: Wong-Baeza, I, et al.
Pubblicazione: (2011)

Genetics of ulcerative colitis.
di: Satsangi, J, et al.
Pubblicazione: (1996)

Study on relationship between platelet transfusion efficacy and KIR-HLA receptor-ligand compatibility
di: Yu HAN, et al.
Pubblicazione: (2023-07-01)